194 related articles for article (PubMed ID: 29596836)
21. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.
Nakatsugawa M; Takahashi A; Hirohashi Y; Torigoe T; Inoda S; Murase M; Asanuma H; Tamura Y; Morita R; Michifuri Y; Kondo T; Hasegawa T; Takahashi H; Sato N
Lab Invest; 2011 Dec; 91(12):1796-804. PubMed ID: 21931300
[TBL] [Abstract][Full Text] [Related]
22. Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells.
Sun Y; Zhang Z; Xiang F; Zhang M; Chen Q; Tang L; Zhu L; Liu J; Meng Z; Hu J; Luo X; Ni Z; Wang X
Life Sci; 2020 Apr; 246():117428. PubMed ID: 32057901
[TBL] [Abstract][Full Text] [Related]
23. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma.
Okudela K; Hayashi H; Ito T; Yazawa T; Suzuki T; Nakane Y; Sato H; Ishi H; KeQin X; Masuda A; Takahashi T; Kitamura H
Am J Pathol; 2004 Jan; 164(1):91-100. PubMed ID: 14695323
[TBL] [Abstract][Full Text] [Related]
24. CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma.
Sun L; Bai L; Lin G; Wang R; Liu Y; Cai J; Guo Y; Zhu Z; Xie C
Oncotarget; 2015 Aug; 6(24):20685-96. PubMed ID: 26023733
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
26. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
27. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
28. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
29. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
[TBL] [Abstract][Full Text] [Related]
30. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
[TBL] [Abstract][Full Text] [Related]
31. Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice.
Tang H; Liao Y; Xu L; Zhang C; Liu Z; Deng Y; Jiang Z; Fu S; Chen Z; Zhou S
Int J Cancer; 2013 Nov; 133(10):2473-82. PubMed ID: 23649836
[TBL] [Abstract][Full Text] [Related]
32. Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway.
Chen J; Yuan J; Zhou L; Zhu M; Shi Z; Song J; Xu Q; Yin G; Lv Y; Luo Y; Jia X; Feng L
Biomed Pharmacother; 2017 Mar; 87():118-126. PubMed ID: 28049093
[TBL] [Abstract][Full Text] [Related]
33. miR-494-3p is a novel tumor driver of lung carcinogenesis.
Faversani A; Amatori S; Augello C; Colombo F; Porretti L; Fanelli M; Ferrero S; Palleschi A; Pelicci PG; Belloni E; Ercoli G; Degrassi A; Baccarin M; Altieri DC; Vaira V; Bosari S
Oncotarget; 2017 Jan; 8(5):7231-7247. PubMed ID: 27980227
[TBL] [Abstract][Full Text] [Related]
34. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
Guan G; Li R; Tang W; Liu T; Su Z; Wang Y; Tan J; Jiang S; Wang K
Tumour Biol; 2017 Mar; 39(3):1010428317691740. PubMed ID: 28347232
[TBL] [Abstract][Full Text] [Related]
35. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
Zhang B; Liu ZM; Hao FG; Wang M
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
[TBL] [Abstract][Full Text] [Related]
36. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer.
Geng J; Li X; Zhou Z; Wu CL; Dai M; Bai X
Cancer Lett; 2015 Apr; 359(2):275-87. PubMed ID: 25633838
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
[TBL] [Abstract][Full Text] [Related]
38. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
Guo L; Wang J; Yang P; Lu Q; Zhang T; Yang Y
IUBMB Life; 2015 Sep; 67(9):720-5. PubMed ID: 26314828
[TBL] [Abstract][Full Text] [Related]
40. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
